title: Measles and rubella eradication in the Americas.
abstract: The challenge for regions embarking on measles elimination will be to maintain high population immunity with excellent vaccination coverage and high-quality surveillance. Meeting this challenge will be especially critical for dealing with importations of measles virus that will occur as long as the virus is circulating anywhere in the world. Implementation of measles elimination strategies will uncover the "hidden" disease burden of rubella and congenital rubella syndrome. As was the experience in countries of Latin America and the Caribbean (LAC), integrating the elimination of measles with the elimination of rubella will greatly enhance the capacity of countries to sustain progress in the reduction of measles mortality. Countries of LAC prioritized the routine national immunization program over short-term successes. While doing so, they have also encountered new opportunities to expand the benefits of disease control and elimination activities to other aspects of public health, most importantly towards improving health care for women and newborns and reducing inequities in health in the region's poorest communities. Implementation of similar strategies could lead to the global eradication of measles, rubella, and congenital rubella syndrome early this century, while strengthening routine immunization programs, and developing the capacity to introduce new and underutilized vaccines.
authors.affiliation: Pan American Health Organization, 525 23rd Street, NW, Washington, DC, USA. andrusjo@paho.org
authors.forename: Jon Kim
authors.initials: JK
authors.lastname: Andrus
authors.forename: Ciro A
authors.initials: CA
authors.lastname: de Quadros
authors.forename: Carlos Castillo
authors.initials: CC
authors.lastname: Solórzano
authors.forename: Mirta Roses
authors.initials: MR
authors.lastname: Periago
authors.forename: D A
authors.initials: DA
authors.lastname: Henderson
mesh_terms: D000569:Americas / Q000453:epidemiology; D060740:Disease Eradication / Q000379:methods* / Q000458:organization & administration*; D006801:Humans; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D012409:Rubella / Q000453:epidemiology* / Q000517:prevention & control*; D014611:Vaccination / Q000379:methods / Q000706:statistics & numerical data